Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CJRB-101
i
Other names:
CJRB-101
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CJ Biosci
Drug class:
Microbiome modulator
Related drugs:
‹
ART12 (1)
BMC128 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT013 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
ART12 (1)
BMC128 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT013 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
›
Associations
News
Trials
Filter by
Latest
11ms
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer (clinicaltrials.gov)
P1/2, N=160, Recruiting, CJ Bioscience, Inc. | Not yet recruiting --> Recruiting
11 months ago
Enrollment open • Combination therapy • Metastases
|
BRAF (B-raf proto-oncogene)
|
PD-L1 expression • BRAF mutation • BRAF V600
|
Keytruda (pembrolizumab) • CJRB-101
over1year
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer (clinicaltrials.gov)
P1/2, N=160, Not yet recruiting, CJ Bioscience, Inc.
over 1 year ago
New P1/2 trial • Combination therapy • Metastases
|
BRAF (B-raf proto-oncogene)
|
PD-L1 expression • BRAF mutation • BRAF V600
|
Keytruda (pembrolizumab) • CJRB-101
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login